Laboratorios Farmacéuticos Rovi, from Spain

Listed in:

Business: Chemistry, Pharmaceutical, Healthcare,

Auditor: PWC.

Last Balances States (Mn of EUR)

Date H1-2014 H1-2013 Var (%)
Total Assets 247.640 229.376 7.96
Total Liabilities
96.483
95.983 0.52
Equity
151.157
133.393 13.32
Working Capital
92.025
81.103 13.47
March 10, 2016

Basic Stock Information

Last Quote (EUR)
14.240
PER
30.93
Capitalization (Mns of EUR)
710.683
Capitalization/Equity
4.7016
Last month variation (%)
3.942
Last 3 months variation (%)
0.565
Last 6 months variation (%)
11.163
Last 12 months variation (%)
3.790

Last Financial Statement (Mn of EUR)

Date H1-2014 H1-2013 Var (%)
Revenue
116.304
109.614 6.1
EBIT
16.648
15.155 9.85
Net Profit
14.955
13.830 8.13
ROCE (%) 9.057 9.026 0.34
ROE 0.099 0.104 -4.81
ROA 0.060 0.060 0.0
Net Profit over revenue 0.129 0.126 2.38
EBIT over revenue 0.143 0.138 3.62
EBITDA over revenue 0.166 0.162 2.47
Assets Rotation 0.470 0.478 -1.67
Earning per share (EUR) 0.29910 0.27660 8.13

Stock-Market Evolution

Key Figures (EUR)

Period Revenue EBITDA EBIT Earning before taxes Net Profit Net Profit over revenue EBIT over revenue ROE ROA Working Capital
H1 116.304 19.318 16.648 15.834 14.955 0.129 0.143 0.099 0.060 92.025 Details
Period Revenue EBITDA EBIT Earning before taxes Net Profit Net Profit over revenue EBIT over revenue ROE ROA Working Capital
Annual 217.587 31.057 25.472 24.251 23.022 0.106 0.117 0.159 0.098 79.143 Details
H2 107.973 13.314 10.317 9.725 9.192 0.085 0.096 0.064 0.039 79.143 Details
H1 109.614 17.743 15.155 14.526 13.830 0.126 0.138 0.104 0.060 81.103 Details
Period Revenue EBITDA EBIT Earning before taxes Net Profit Net Profit over revenue EBIT over revenue ROE ROA Working Capital
Annual 201.923 25.761 21.677 20.838 19.514 0.097 0.107 0.154 0.088 75.910 Details
H2 97.047 10.487 8.095 7.525 6.555 0.068 0.083 0.052 0.029 75.910 Details
H1 104.876 15.274 13.582 13.313 12.959 0.124 0.130 0.108 0.059 88.488 Details
Period Revenue EBITDA EBIT Earning before taxes Net Profit Net Profit over revenue EBIT over revenue ROE ROA Working Capital
Annual 184.706 20.241 18.985 18.928 18.127 0.098 0.103 0.159 0.079 112.421 Details
H2 88.819 5.312 5.047 5.637 5.253 0.059 0.057 0.046 0.023 112.421 Details
H1 95.887 14.929 13.938 13.291 12.874 0.134 0.145 0.119 0.059 112.981 Details
Period Revenue EBITDA EBIT Earning before taxes Net Profit Net Profit over revenue EBIT over revenue ROE ROA Working Capital
Annual 158.645 28.096 26.003 25.921 24.582 0.155 0.164 0.236 0.115 110.304 Details
H2 85.926 6.581 5.685 5.725 5.653 0.066 0.066 0.054 0.027 110.304 Details
H1 72.719 21.515 20.318 20.196 18.929 0.260 0.279 0.192 0.091 104.788 Details
Period Revenue EBITDA EBIT Earning before taxes Net Profit Net Profit over revenue EBIT over revenue ROE ROA Working Capital
Annual 141.809 23.893 25.524 24.430 20.141 0.142 0.180 0.231 0.122 87.594 Details
H2 81.452 15.431 16.464 15.961 13.131 0.161 0.202 0.151 0.080 87.594 Details
H1 60.357 9.886 9.060 8.469 7.010 0.116 0.150 0.100 0.048 65.698 Details
Period Revenue EBITDA EBIT Earning before taxes Net Profit Net Profit over revenue EBIT over revenue ROE ROA Working Capital
Annual 127.544 25.221 28.320 28.158 23.542 0.185 0.222 0.343 0.173 63.551 Details
H2 68.535 11.289 14.143 14.011 12.355 0.180 0.206 0.180 0.091 63.551 Details
H1 59.009 14.893 14.177 14.147 11.187 0.190 0.240 0.177 0.097 50.917 Details

Additional information

  • Capitalization: Total number of shares x (1 - Treasury shares) x Last Quote = (50000000) x (1 - 0.00185 ) x (14.240 EUR) = 710.683 Mns of EUR
  • PER: Last Quote (14.240 EUR) / Last annual earning per share (0.46044) = 30.927

News